Delivering Affordable Cancer Care in the 21st Century : : workshop summary / / Erin Balogh, Margie Patlak, and Sharyl J. Nass, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies.

• Author: Delivering Affordable Cancer Care in the 21st Century (Workshop) Washington, D.C.),
• TeilnehmendeR: Balogh, Erin,; Patlak, Margie,; Nass, Sharyl J.,; National Cancer Policy Forum (U.S.),; Institute of Medicine (U.S.). Board on Health Care Services,
• Place / Publishing House: Washington, District of Columbia : : National Academies Press,, [2013]; 2013
• Year of Publication: 2013
• Language: English
• Physical Description: 1 online resource (94 pages) :; illustrations (some color), color map

"Rising health care costs are a central fiscal challenge confronting the United States. National spending on health care currently accounts for 18 percent of gross domestic product (GDP), but is anticipated to increase to 25 percent of GDP by 2037. The Bipartisan Policy Center argues that "this rapid growth in health expenditures creates an unsustainable burden on America's economy, with far-reaching consequences". These consequences include crowding out many national priorities, including investments in education, infrastructure, and research; stagnation of employee wages; and decreased international competitiveness. In spite of health care costs that far exceed those of other countries, health outcomes in the United States are not considerably better. With the goal of ensuring that patients have access to high-quality, affordable cancer care, the Institute of Medicine's (IOM's) National Cancer Policy Forum convened a public workshop, Delivering Affordable Cancer Care in the 21st Century, October 8-9, 2012, in Washington, DC. Delivering Affordable Cancer Care in the 21st Century summarizes the workshop"-- Publisher's description.

Table of Contents

Introduction -- A financial crisis in health care -- Drivers of health care costs -- Cancer care costs -- Financial burden on patients with cancer -- Questionable value -- Current challenges -- Inappropriate incentives -- Unrealistic expectations -- Overuse and misuse of interventions -- Variable care, lack of best practices, and an inadequate evidence base -- Legal and regulatory issues -- Assessing value -- Possible solutions -- Patient and clinician communication and education -- Best practices in cancer care -- Evidence base for clinical practice and reimbursement -- Financial incentives aligned with affordable, high-quality cancer care -- Delivery system and reimbursement changes -- Wrap up.